Akdis Mübeccel
Swiss Institute of Allergy and Asthma Research (SIAF), Obere Strasse 22, CH-7270 Davos, Switzerland.
Expert Opin Biol Ther. 2008 Jun;8(6):769-77. doi: 10.1517/14712598.8.6.769.
Specific immune response to allergens is decisive in the development of clinically healthy or allergic states.
Recent developments in the mechanisms of allergen-specific peripheral tolerance can be used for future treatment modalities.
This review focuses on recent developments in allergen tolerance.
RESULTS/CONCLUSION: The balance between allergen-specific IL-10-secreting T regulatory cells (Tr1) and T helper 2 (Th2) cells appears to be decisive in the development of allergic and healthy immune response against allergens. Induction of IL-10- and TGF-beta-producing Tr1 cells, IgG4-isotype-blocking antibodies, and suppressed mast cells, basophils and eosinophils represent major components of a relatively normalized immune response after allergen-specific immunotherapy and healthy immune response to aeroallergens in sensitized individuals.
对变应原的特异性免疫反应在临床健康或过敏状态的发展中起决定性作用。
变应原特异性外周耐受机制的最新进展可用于未来的治疗方式。
本综述聚焦于变应原耐受的最新进展。
结果/结论:变应原特异性分泌白细胞介素-10的调节性T细胞(Tr1)与辅助性T细胞2(Th2)之间的平衡似乎在针对变应原的过敏和健康免疫反应的发展中起决定性作用。诱导产生白细胞介素-10和转化生长因子-β的Tr1细胞、IgG4同种型阻断抗体以及受抑制的肥大细胞、嗜碱性粒细胞和嗜酸性粒细胞是变应原特异性免疫治疗后相对正常化免疫反应以及致敏个体对气传变应原的健康免疫反应的主要组成部分。